Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
中文简介正在准备中。当前显示原文说明。
Use when packaging AISTATS code, data, proofs, simulation scripts, notebooks, random seeds, and logs as anonymous supplementary evidence or public post-acceptance artifacts, even when there is no separate artifact badge. Covers what statistically minded AISTATS reviewers inspect first and how to make Monte Carlo studies turnkey.
中文简介正在准备中。当前显示原文说明。
实测评分 未实测
查看安装方法安装前可以查看交给 AI 代理的指令内容。
Use this for evidence packaging around AISTATS. The venue centers on artificial intelligence, statistics, and machine learning, so artifacts should make statistical and computational claims inspectable.
| Claim type | First artifact inspected | Common failure caught |
|---|---|---|
| Convergence rate or regret bound | Proof appendix and constants | Condition used in the proof but missing from the theorem statement |
| Monte Carlo simulation | Seeded simulation script | Plots cannot be regenerated because seeds and replication counts are absent |
| Benchmark comparison | Training and evaluation configs | Baseline tuning budget undocumented |
| Bayesian or MCMC method | Sampler diagnostics and chain logs | No convergence statistics or trace evidence anywhere |
Because AISTATS reviewers are often statisticians, they will rerun a small simulation far more readily than they will retrain a deep model, so make synthetic studies turnkey before polishing anything else.
A hypothetical submission proposes a doubly robust treatment-effect estimator with a root-n normality guarantee, validated on synthetic causal data plus two real benchmarks.
[Artifact role] anonymous supplement / camera-ready release / public archive
[Contents] <code/data/proofs/logs/notebooks>
[Anonymity risks] <paths/metadata/licenses/URLs>
[Reproduction level] turnkey / scripted / descriptive / weak
[Fixes before upload] <ordered list>
还没有评价。欢迎分享你的使用感受。
无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。
还没有评论。来写第一条吧。
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
中文简介正在准备中。当前显示原文说明。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
中文简介正在准备中。当前显示原文说明。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
中文简介正在准备中。当前显示原文说明。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
中文简介正在准备中。当前显示原文说明。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
中文简介正在准备中。当前显示原文说明。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
中文简介正在准备中。当前显示原文说明。